live In the news:
EU slaps Israeli generic drugmaker Teva with $500M antitrust fine - EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug - EU Commission fines Teva $500M for trying to stop rival's multiple sclerosis drug - Teva Fined Around $500 Million Over MS Drug Competition Concerns - European Commission fines MS drug maker Teva over improper patent use - EU fines world's largest generic drugmaker Teva for hindering competition - EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug

Teva.Gr

9 days ago
bookmarkSave

Key facts

Classified as: organization

Summary

Teva.Gr is a company. It is located in Agia Varvara, Greece. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.

Business see more

  • Employees: get premium Premium to see estimate
  • Revenues: get premium Premium to see estimate

Stocks from Teva.Gr

Talking Points:

  • Teva Greece
  • Official Teva Pharmaceuticals Europe Twitter feed. We develop, produce, and market medicines that make a difference in people's lives.
Learn more about talking points

In literature

There is no book written about Teva.Gr in the database

Related

Connected or similar:

Details

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter

This content can be used under the CC BY 4.0 license